Literature DB >> 10939642

Vanadium and diabetes. What about vanadium toxicity?: A reply.

J H McNeill1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10939642     DOI： 10.1023/a:1007019129085

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN： 0300-8177            Impact factor:   3.396


× No keyword cloud information.
  10 in total

1.  In vitro and in vivo antineoplastic effects of orthovanadate.

Authors:  T F Cruz; A Morgan; W Min
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 2.  Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects.

Authors:  I G Fantus; E Tsiani
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

3.  Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology.

Authors:  J J Mongold; G H Cros; L Vian; A Tep; S Ramanadham; G Siou; J Diaz; J H McNeill; J J Serrano
Journal:  Pharmacol Toxicol       Date:  1990-09

4.  Toxicity studies on one-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate.

Authors:  S Dai; K H Thompson; E Vera; J H McNeill
Journal:  Pharmacol Toxicol       Date:  1994-11

5.  Effect of vanadate on reproductive efficiency in normal and streptozocin-treated diabetic rats.

Authors:  S Ganguli; D J Reuland; L A Franklin; M Tucker
Journal:  Metabolism       Date:  1994-11       Impact factor: 8.694

Review 6.  Vanadium and diabetes.

Authors:  P Poucheret; S Verma; M D Grynpas; J H McNeill
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

7.  One-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate did not alter blood pressure or haematological indices.

Authors:  S Dai; J H McNeill
Journal:  Pharmacol Toxicol       Date:  1994-02

8.  One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate.

Authors:  S Dai; K H Thompson; J H McNeill
Journal:  Pharmacol Toxicol       Date:  1994-02

9.  Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV).

Authors:  V G Yuen; C Orvig; K H Thompson; J H McNeill
Journal:  Can J Physiol Pharmacol       Date:  1993 Mar-Apr       Impact factor: 2.273

10.  Effects of maternal vanadate treatment of fetal development.

Authors:  S Ganguli; D J Reuland; L A Franklin; D D Deakins; W J Johnston; A Pasha
Journal:  Life Sci       Date:  1994       Impact factor: 5.037
  10 in total
  2 in total

1.  New vanadium-based magnetic resonance imaging probes: clinical potential for early detection of cancer.

Authors:  Devkumar Mustafi; Bo Peng; Sean Foxley; Marvin W Makinen; Gregory S Karczmar; Marta Zamora; John Ejnik; Heather Martin
Journal:  J Biol Inorg Chem       Date:  2009-07-02       Impact factor: 3.358

Review 2.  Why Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical Review.

Authors:  Thomas Scior; Jose Antonio Guevara-Garcia; Quoc-Tuan Do; Philippe Bernard; Stefan Laufer
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.